The Next Global Ingredient Delivery Platform
A patented delivery system built into a drinking straw.
Functional and therapeutic ingredients dissolve as you sip. Consistent dosing. Shelf-stable. No pills, powders, or gummies.
How it works
DS² technology uses proprietary slurry + adhesion chemistry. Works with vitamins, minerals, pharmaceuticals, nutraceuticals, cannabinoids, and more.
All rights reserved 2026 Sipit Technologies, Inc. / SipIt, Inc.
Why it matters
Consumer fatigue
People are tired of swallowing pills and mixing powders. This is intuitive and familiar.
Format bottleneck
Brands can't keep reinventing delivery. SipIT is a universal platform that works across categories.
Portfolio expansion
Brands can extend into new categories without R&D risk. Add functional benefits to existing beverage lines or create entirely new product families.
Margin opportunity
Premium positioning. The straw format commands higher price points while reducing manufacturing complexity.
One Platform. Infinite Applications.
SipIT is a blank canvas for functional and therapeutic delivery across every category.
Energy & Focus
(caffeine, B-vitamins, nootropics)
Calm & Stress Relief
(adaptogens, L-theanine, magnesium)
Sleep Support
(melatonin, valerian, GABA)
Immunity Boost
(vitamin C, zinc, elderberry)
Daily Vitamins
(multivitamins, vitamin D, B-complex)
Minerals & Electrolytes
(sodium, potassium, magnesium)
Hydration Support
(electrolyte balance, rehydration, performance hydration)
Protein & Amino Acids
(BCAAs, collagen, creatine)
Weight Management
(metabolism support, appetite control)
Pediatric Dosing
(no choking hazard, precise delivery)
Geriatric Care
(easy swallowing, compliance support)
Dysphagia Support
(swallowing difficulty, thickened liquids alternative, safe medication delivery)
Pain Management
(NSAIDs, analgesics)
Chronic Disease Support
(diabetes, cardiovascular, GI)
Oncology Support
(anti-nausea, appetite stimulation, symptom management)
Neurological Care
(seizure management, cognitive support, neuroprotection)
GI & Digestive Health
(probiotics, digestive enzymes, gut health support)
Respiratory Support
(asthma management, bronchodilators, mucolytics)
Pharmaceutical APIs
(synthetic drugs, prescription actives, controlled substances)
Botanical & Herbal APIs
(natural plant extracts, phytochemicals, herbal medicines)
Flavor Enhancement
(natural extracts, essences)
Libation Creativity
(beverage enhancement, mixology innovation, elevated drinking experiences)
Functional Beverages
(enhanced water, sports drinks)
Alcohol Alternatives
(mood support without alcohol)
Custom Formulations
(brand-specific blends)
If it can be formulated, it can be delivered through SipIT.
Eight High-Value Markets Ready for Disruption
From wellness to defense, SipIT delivers across every sector.
Functional Beverages & Wellness
Enhanced water, sports drinks, daily supplements, and functional hydration products
Nutraceuticals & Supplements
Vitamins, minerals, adaptogens, nootropics, and daily wellness formulations
Pharmaceutical & Clinical
Pediatric medications, geriatric care, pain management, and chronic disease support
Sports & Performance
Electrolytes, amino acids, protein delivery, pre-workout, and recovery formulations
Hospitality & Food Service
Custom beverage programs, flavor enhancement, and premium guest experiences
Military & Defense
Field-ready nutrition, hydration systems, and performance support for deployed personnel
Education & Institutional
Student wellness programs, campus health initiatives, and institutional nutrition
Disaster Relief & Humanitarian
Portable nutrition, emergency hydration, and critical ingredient delivery in crisis zones
A Multi-Trillion Dollar Opportunity
SipIT sits at the intersection of the world's fastest-growing consumer health markets.
$440B
Functional Food & Beverages
$440B growing to $983B by 2034
$591B
Nutraceuticals
$591B projected to hit $919B by 2030
$156B
Dietary Supplements & Vitamins
$156B heading toward $275B by 2030
$52B
Sports Nutrition
$52B on pace for $100B+ by 2034
$77B
Probiotics
$77B climbing to $115B by 2030
$40B
Electrolyte & Hydration
$40B and accelerating
$13B
Adaptogens & Botanicals
$13B growing to $17B+ by 2030
$300B
Drug Delivery Systems
$300B expanding at 10.2% CAGR
$187B
Contract Manufacturing & White Label
$187B on track for $283B by 2030
SipIT's platform-agnostic model means every dollar of growth in these markets is a potential licensing, co-manufacturing, or white-label opportunity.
CPG & Brand Partners
Speed to shelf. Consumer adoption. No behavior change.
Seamless Integration
Integrate into existing product lines without reformulation, minimizing development time and costs.
Familiar User Experience
Consumers already know how to use a straw, ensuring quick adoption with no new behavior to learn.
Portable & Intuitive
Our format is portable, intuitive, and kid-friendly, making it ideal for on-the-go consumption.
Sustainable Solution
Plant-based and fast-composting, our technology offers a compelling sustainability story for your brand.
Partnership Models
Licensing
Your brand, our innovative technology.
Co-Brand
Joint product development and market launch.
Contract Manufacturing
White label production tailored to your needs.
We're looking for: Brands in wellness, functional beverages, sports nutrition, and pediatric health.
Start a conversation
All rights reserved 2026 Sipit Technologies, Inc. / SipIt, Inc.
Pharma & Biotech BD
Precise dosing. Taste masking. Compliance-ready.
Consistent, repeatable dosing without user error
Taste masking for bitter actives
No cold chain required (12+ month shelf life at room temperature)
Pediatric and geriatric applications (no swallowing difficulty)
Direct oral delivery, faster onset than pills/gummies
What we've tested:
  • Vitamins, minerals, electrolytes
  • Amino acids, adaptogens, nootropics
  • Pharmaceutical-grade actives (compatible with broad molecular weight range)
  • Platform designed to integrate with liposomal, nano-emulsion, and bioenhancer technologies
Data and pilots:
  • HPLC analysis for potency validation
  • Dissolution rate testing
  • Stability studies completed
  • Ready for clinical pilot programs
All rights reserved 2026 Sipit Technologies, Inc. / SipIt, Inc.
Traction & Proof Points
Early validation across technology, formulation, and market readiness.
✅ DS² Technology Validated
HPLC potency analysis, dissolution rate testing, and stability studies completed. Platform performs across vitamins, minerals, amino acids, adaptogens, and pharmaceutical-grade actives.
✅ Shelf-Stable Formula
12+ month room-temperature stability confirmed. No cold chain required.
✅ Broad Compatibility
Tested with liposomal, nano-emulsion, and bioenhancer technologies. Compatible with wide molecular weight range.
✅ Multi-Vertical Interest
Active conversations across CPG, pharma/biotech, and institutional channels.
🚀 Brand Pilots in Motion
Real brands. Real formulations. Real shelves. SipIT is actively running co-development pilots with brand partners — turning interest into product.
✅ IP Protection
Patented architecture and proprietary chemistry. Protection extends beyond formulation.
Additional data, pilot results, and IP documentation available under NDA.
Why Invest in SipIT
Platform play. Category creation. Defensible IP.
Patented Moat
Proprietary DS² architecture and adhesion chemistry. IP protection extends beyond formulation — covering the delivery system itself.
Platform Economics
One technology. Infinite SKUs. Revenue scales through licensing, co-manufacturing, and white-label without linear cost growth.
$1.8T+ Addressable Market
Functional beverages, nutraceuticals, pharma delivery, sports nutrition, and contract manufacturing — all converging on better delivery.
Manufacturing Ready
Validated production. Shelf-stable. No cold chain. Designed for rapid commercial scale without capital-intensive infrastructure.
Multiple Exit Paths
Strategic acquisition by CPG, pharma, or ingredient platform. Licensing rollup. Category-defining IPO candidate as the platform scales.
We are selectively engaging strategic investors and partners. This teaser is shared pre-NDA — full financials, IP documentation, and pilot data available upon execution of NDA.
All rights reserved 2026 Sipit Technologies, Inc. / SipIt, Inc.
Start a conversation
Tell us what you're interested in
Whether you're interested in CPG/brand partnerships, pharma/biotech BD, investment opportunities, or media inquiries, reach out directly.
Email: Cree@SipitTech.com
Location: Austin, TX
All rights reserved 2026 Sipit Technologies, Inc. / SipIt, Inc.
This Is Just the Beginning
You're viewing a pre-NDA teaser. The full story is behind the NDA.
Sign the NDA
A simple, standard mutual NDA. Executed digitally in minutes.
Access the Full Deck
Complete financials, IP documentation, pilot data, manufacturing specs, and partnership terms.
Start a Conversation
Direct access to the founding team. No intermediaries.
SipIT is not just a product. It's a platform. And platforms get acquired, licensed, and scaled.
Cree@SipitTech.com · Austin, TX · SipitTech.com
All rights reserved 2026 Sipit Technologies, Inc. / SipIt, Inc.